RankAlpha logo
Back to Rankings

XBIO

Xenetic BiosciencesC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
XBIO vs peer average
53/100
XBIO vs. peer average (C vs. C)
Grade spread
A 3 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

PLX is the first available peer comparator.

Protalix BioTherapeutics is the closest public mechanism comparator identified: its research-stage PRX-119 is a long-acting recombinant human DNase I candidate intended to degrade neutrophil extracellular traps. It is not an oncology-stage valuation peer because its DNase program targets broader NET-related diseases and Protalix also has commercial products, but it provides relevant evidence for DNase development and platform differentiation.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPLXProtalix Biotherapeutics
XBIO
Xenetic Biosciences
PLX
Protalix Biotherapeutics
Grade
C
A
Momentum
63
98
Value
57
64
Sentiment
52
65
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs PLX

XBIO / PLX
Grade Position
In line
XBIO vs. peer average (C vs. C)
53/100
Momentum
63
PLX
Value
57
PLX
Sentiment
52
PLX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XBIO
1
PLX
PLX
A
100/100
+2
2
PPBT
PPBT
D
40/100
-1
3
ALP
Alpha Compute Corp Common
F
20/100
-2
4
PULM
Pulmatrix Inc Common
D
40/100
-1
5
CDIO
Cardio Diagnostics Holdings Inc Common
C
60/100
Even
PLX is the first peer returned for this comparison set.